Literature DB >> 17920044

Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors.

Yukihiro Ohno1, Hiroshi Hibino, Christoph Lossin, Atsushi Inanobe, Yoshihisa Kurachi.   

Abstract

The inwardly rectifying K+ (Kir) channel Kir4.1 is responsible for astroglial K+ buffering. We recently found that tricyclic antidepressants (TCAs) inhibit Kir4.1 channel currents, which suggests that astroglial Kir currents might be involved in the pharmacological action of antidepressants. We therefore further examined the effects of the currently most popular antidepressants, selective serotonin reuptake inhibitors (SSRIs), and other related agents on Kir4.1 channels heterologously expressed in HEK293T cells. The whole-cell patch clamp technique was used. Fluoxetine, the typical SSRI, inhibited Kir4.1 channel currents in a concentration-dependent manner with an IC50 value of 15.2 microM. The inhibitory effect of fluoxetine was reversible and essentially voltage-independent. Fluoxetine had little or no effect upon Kir1.1 (ROMK1) or Kir2.1 (IRK1) channel currents. Other SSRIs, sertraline and fluvoxamine, also inhibited Kir4.1 channel currents whereas the tetracyclic (mianserin) or the 5-HT1A receptor-related (buspirone) antidepressants did not. This study shows that SSRIs such as fluoxetine and sertraline preferentially block astroglial Kir4.1 rather than Kir1.1 or Kir2.1 channels in the brain, which may be implicated in their therapeutic and/or adverse actions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920044     DOI: 10.1016/j.brainres.2007.08.018

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  42 in total

1.  A novel mitochondrial K(ATP) channel assay.

Authors:  Andrew P Wojtovich; David M Williams; Marcin K Karcz; Coeli M B Lopes; Daniel A Gray; Keith W Nehrke; Paul S Brookes
Journal:  Circ Res       Date:  2010-02-25       Impact factor: 17.367

Review 2.  Small-molecule modulators of inward rectifier K+ channels: recent advances and future possibilities.

Authors:  Gautam Bhave; Daniel Lonergan; Brian A Chauder; Jerod S Denton
Journal:  Future Med Chem       Date:  2010-05       Impact factor: 3.808

3.  Dietary K+ and Cl- independently regulate basolateral conductance in principal and intercalated cells of the collecting duct.

Authors:  Viktor N Tomilin; Oleg Zaika; Arohan R Subramanya; Oleh Pochynyuk
Journal:  Pflugers Arch       Date:  2017-11-13       Impact factor: 3.657

4.  Pressure-dependent modulation of inward-rectifying K+ channels: implications for cation homeostasis and K+ dynamics in glaucoma.

Authors:  Rachel A Fischer; Abigail L Roux; Lauren K Wareham; Rebecca M Sappington
Journal:  Am J Physiol Cell Physiol       Date:  2019-06-05       Impact factor: 4.249

Review 5.  Breakdown of blood brain barrier as a mechanism of post-traumatic epilepsy.

Authors:  Aaron Dadas; Damir Janigro
Journal:  Neurobiol Dis       Date:  2018-07-18       Impact factor: 5.996

6.  Selective serotonin reuptake inhibitor sertraline inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.

Authors:  Han Sol Kim; Hongliang Li; Hye Won Kim; Sung Eun Shin; Il-Whan Choi; Amy L Firth; Hyoweon Bang; Young Min Bae; Won Sun Park
Journal:  J Biosci       Date:  2016-12       Impact factor: 1.826

Review 7.  Role and mechanisms of regulation of the basolateral Kir 4.1/Kir 5.1K+ channels in the distal tubules.

Authors:  O Palygin; O Pochynyuk; A Staruschenko
Journal:  Acta Physiol (Oxf)       Date:  2016-05-20       Impact factor: 6.311

Review 8.  Novel diuretic targets.

Authors:  Jerod S Denton; Alan C Pao; Merritt Maduke
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

9.  Sertraline inhibits the transport of PAT1 substrates in vivo and in vitro.

Authors:  C U Nielsen; S Frølund; S Abdulhadi; H Sari; L Langthaler; M K Nøhr; M A Kall; B Brodin; R Holm
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

10.  Inhibition of Kir4.1 potassium channels by quinacrine.

Authors:  Leticia G Marmolejo-Murillo; Iván A Aréchiga-Figueroa; Meng Cui; Eloy G Moreno-Galindo; Ricardo A Navarro-Polanco; José A Sánchez-Chapula; Tania Ferrer; Aldo A Rodríguez-Menchaca
Journal:  Brain Res       Date:  2017-03-11       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.